FVCB vs GILD · P/E 13, rev $1.0M vs P/E 18, rev $7.80B
FVCBankcorp Inc (FVCB) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
FVCBankcorp Inc (FVCB) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FVCB revenue for 2026-06-30 was $1.0M. Net income was $14.6M. FVCB currently screens at market cap $234.1M and trailing P/E 12.6.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FVCB currently screens at market cap $234.1M and trailing P/E 12.6. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FVCB and GILD stock pages for the full models.
Not investment advice.